NCAA Policy on Transgender Student-Athlete Participation

The following policies clarify participation of transgender student-athletes undergoing hormonal treatment for
gender transition:

1. A trans male (FTM) student-athlete who has received a medical exception for treatment with testosterone
for diagnosed Gender Identity Disorder or gender dysphoria and/or Transsexualism, for purposes
of NCAA competition may compete on a men’s team, but is no longer eligible to compete on a women’s
team without changing that team status to a mixed team.
2. A trans female (MTF) student-athlete being treated with testosterone suppression medication for
Gender Identity Disorder or gender dysphoria and/or Transsexualism, for the purposes of NCAA competition
may continue to compete on a men’s team but may not compete on a women’s team without
changing it to a mixed team status until completing one calendar year of testosterone suppression
treatment.8
 
Any transgender student-athlete who is not taking hormone treatment related to gender transition may participate
in sex-separated sports activities in accordance with his or her assigned birth gender.

• A trans male (FTM) student-athlete who is not taking testosterone related to gender transition may
participate on a men’s or women’s team.
• A trans female (MTF) transgender student-athlete who is not taking hormone treatments related to
gender transition may not compete on a women’s team.
 
You may review the entire NCAA policy by visiting http://www.ncaa.org/sites/default/files/Transgender_Handbook_2011_Final.pdf.